Enzyme Replacement Therapy Market - Global Industry Analysis
Enzyme Replacement Therapy Market: by Enzyme (pegademase, velaglucerase alfa, agalsidase beta, imiglucerase, taliglucerase, laronidase, alglucosidase alfa, and other enzymes), therapeutic condition (Pompe’s disease, Gaucher’s disease, MPS, Fabry’s disease, SCID, and others), Route of administration (oral and parenteral) and End user (hospitals, infusion centers, and others) – Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025
Published Date: 26-Nov-2019Healthcare
Category: Report Format : PDF
Report Code: ZMR-5094
Status : Published
Global demand for Enzyme Replacement Therapy Market was valued at approximately USD 6462.6 Million in 2018, and is expected to generate revenue of around USD 9581.64 Million by end of 2025, growing at a CAGR of around 5.81% between 2018 and 2025.